The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Research Funding - CytRx Corporation (Inst)
Efficacy and safety of adding the retinoid tamibarotene or placebo to paclitaxel/carboplatin for advanced non-small cell lung cancer.
 
Oscar Arrieta
No Relationships to Disclose
 
Daniel J. Levitt
Employment - CytRx Corporation
Leadership - CytRx Corporation
Stock and Other Ownership Interests - CytRx Corporation
Patents, Royalties, Other Intellectual Property - CytRx Corporation
 
Kelly B. Pendergrass
Research Funding - CytRx Corporation (Inst)
 
Oleg Gladkov
Research Funding - CytRx Corporation (Inst)
 
Igor Bondarenko
Research Funding - CytRx Corporation (Inst)
 
Minish Mahendra Jain
Research Funding - CytRx Corporation (Inst)
 
Scott Wieland
Employment - CytRx Corporation
Leadership - CytRx Corporation
Stock and Other Ownership Interests - CytRx Corporation